AMD Advanced Micro Devices Inc.

2nd Gen AMD EPYCâ„¢ Processors Power New Oracle Cloud Infrastructure Compute E3 Platform

2nd Gen AMD EPYC™ Processors Power New Oracle Cloud Infrastructure Compute E3 Platform

— Made for high-performance workloads, the Oracle Cloud Infrastructure Compute E3 Platform uses key features of 2nd Gen AMD EPYC™ processors to provide higher core counts and more memory for Oracle Cloud customers —

SANTA CLARA, Calif., April 29, 2020 (GLOBE NEWSWIRE) -- Today, (NASDAQ: AMD) announced that 2nd Gen AMD EPYC™ processors are powering the Oracle Cloud Infrastructure Compute E3 platform, bringing a new level of high-performance computing to Oracle Cloud.

Using the AMD EPYC™ 7742 processor, the Oracle Cloud “E3 standard” and the bare metal compute instances are available today and leverage key features of the Gen AMD EPYC processors including class-leading memory bandwidthi and the highest core count for an x86 data center processor. These features enable the Oracle Cloud E3 platform to be well suited for both general purpose and high bandwidth workloads such as big data analytics, memory intense workloads and Oracle business applications.

“Almost two years ago, we embarked on a very successful collaboration with AMD that brought industry leading performance to numerous enterprise customers running general purpose workloads on Oracle Cloud Infrastructure,” said Vinay Kumar, vice president, product management, Oracle Cloud Infrastructure. “Today, we are launching our new Oracle Cloud E3 platform built on AMD EPYC processors. Customers will have access to virtual machines that support higher core counts, increased memory bandwidth, and the highest core count for any bare metal instance on any public cloud to run any workload.”

“Oracle Cloud has been a key partner for AMD starting with our first generation EPYC products, and we are pleased to continue this strategic collaboration today with our 2nd Gen AMD EPYC processors powering the first Oracle Cloud family of E3 instances,” said Forrest Norrod, senior vice president and general manager, Data Center and Embedded Solutions Group, AMD. “The high core count and memory bandwidth delivered by 2nd Gen AMD EPYC enables our customers, like Oracle Cloud, to provide their end users with exceptional performance and throughput for critical workloads in the cloud.”

Enabling High Performance Cloud Computing at Oracle

Powered by the AMD EPYC 7742 processor, the Oracle Cloud E3 Platform enables customers to run high performance computing (HPC) workloads such as risk simulations, molecular modeling, and contextual search.

By using the AMD EPYC 7742 processor, Oracle Cloud E3 platform can deliver even more computing performance capabilities to their growing cloud customer base, including:

  • The ability to launch higher core count VMs, which now includes VMs up to 64 cores, each including simultaneous multithreading, and bare metal instances up to 128 cores.
  • A higher memory-to-core ratio for memory-intensive workloads. With the high bandwidth capabilities of the AMD EPYC 7742 processor, E3 platform customers get 16 GB of memory per core – double the ratio of the current AMD EPYC™ processor E2 platform.

The Oracle Cloud E3 instances are currently available in US East (Ashburn), US West (Phoenix), Germany Central (Frankfurt), and Japan East (Tokyo). Within a quarter from launch, Oracle plans to have the E3 platform widely available in all its commercial regions.

Supporting Resources

  • Learn more about the Oracle E3 instance on the Oracle blog
  • Learn more about the
  • Become a fan of AMD on
  • Follow AMD on

About AMD

For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) , , and pages.

AMD, the AMD Arrow logo, EPYC, and combinations thereof, are trademarks of Advanced Micro Devices, Inc. Oracle is a registered trademark of Oracle and/or its affiliates. Other names are for informational purposes only and may be trademarks of their respective owners.


i EPYC™ 7002 series has 8 memory channels, supporting 3200 MHz DIMMs yielding 204.8 GB/s of bandwidth vs. the same class of Intel Scalable Gen 2 processors with only 6 memory channels and supporting 2933 MHz DIMMs yielding 140.8 GB/s of bandwidth. 204.8 / 140.8 = 1.454545 - 1.0 = .45 or 45% more. AMD EPYC has 45% more bandwidth. Class based on industry-standard pin-based (LGA) X86 processors. ROM-11

Contact:
Aaron Grabein
AMD Communications
(512) 602-8950
 

Laura Graves
AMD Investor Relations
(408) 749-5467
 
EN
29/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Advanced Micro Devices Inc.

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NKTR NEKTAR THERAPEUTICS
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
ACRS ACLARIS THERAPEUTICS INC.
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ORIC KEROS THERAPEUTICS
ZNTL ORIC PHARMACEUTICALS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
SANA VIRIDIAN THERAPEUTICS INC
PLTK SANA BIOTECHNOLOGY
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
PEPG TYRA BIOSCIENCES INC
EWTX PEPGEN INC
SLDB EDGEWISE THERAPEUTICS INC
DDI SOLID BIOSCIENCES INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B APOGEE THERAPEUTICS INC
DNTH EMBRACER GROUP AB
ORKA DIANTHUS THERAPEUTICS INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
IMA JADE BIOSCIENCES INC
IMAGENEBIO INC.
Pierre FerraguÊ
  • Pierre FerraguÊ

The Tech Infrastructure Quarterly Bible 4Q25

​​​​We publish today our comprehensive quarterly bible: 243 pages of detailed analyses on what happened in the last 3 months, and how we interpret it, in light of our current convictions. The first section acts as a PM summary, outlining our key findings, and latest thoughts on the semi cycle, in 6 slides:

ResearchPool Subscriptions

Get the most out of your insights

Get in touch